May 10, 2022
3 min watch
Save
VIDEO: Bilastine effective against ocular allergy signs, symptoms
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
DENVER – Bilastine 0.6% ophthalmic solution was shown in a phase 3 trial to be comfortable and effective in patients with allergic conjunctivitis, Paul J. Gomes, of Ora Inc. said here at ARVO.
The preservative-free solution from Faes Farma showed efficacy against ocular redness, tearing, lid swelling and nasal symptomatology for up to 16 hours, Gomes said.
Published by:
Sources/Disclosures
Collapse
Source:
Gomes P, et al. A multi-center phase 3 evaluation of bilastine 0.6% preservative-free eye drops for the treatment of allergic conjunctivitis. Presented at: Association for Research in Vision and Ophthalmology meeting; May 1-4, 2022; Denver.
Disclosures:
Gomes is employed by Ora Inc. The study was sponsored by Faes Farma Vizcaya.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.